US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

MACK Merrimack Pharmaceuticals Inc

15.1575

0.00 (0.00%)

Última actualización: 19:00:00

Retrasado por 15 minutos

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Merrimack Pharmaceuticals (NASDAQ:MACK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Merrimack Pharmaceuticals.

Merrimack Pharmaceuticals (NASDAQ:MACK)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Merrimack Pharmaceuticals.

Noticias sobre Merrimack Pharmaceuticals Inc MACK

Form 15-12G - Securities registration termination [Section 12(g)]
Lunes 20 de Mayo 2024 (2 días hace) • Edgar (US Regulatory)

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Viernes 10 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Viernes 10 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Viernes 10 de Mayo 2024 (2 semanas hace) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jueves 9 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Jueves 9 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
Jueves 9 de Mayo 2024 (2 semanas hace) • Business Wire

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Martes 30 de Abril 2024 (3 semanas hace) • Business Wire

Merrimack Receives $225 Million Milestone Payment from Ipsen
Miércoles 27 de Marzo 2024 (2 meses hace) • Business Wire

Form 425 - Prospectuses and communications, business combinations
Jueves 7 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Jueves 7 de Marzo 2024 (2 meses hace) • Edgar (US Regulatory)

Merrimack Reports Full Year 2023 Financial Results
Jueves 7 de Marzo 2024 (2 meses hace) • Business Wire

Más de Merrimack Pharmaceuticals Inc Artículos de Noticias

Health Care Select Sector

Bank of America

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones